CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- SC 13G Stake Amended Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 21,100 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 18,750 shares (grant or award)
- 4 Grant or award President and CEO acquired 82,050 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 25,800 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Regulation FD disclosure
- 4 Gift President and CEO gave 2,000 shares (gift)
- SC 13G Stake Amended Statement of Ownership
Page 27 of 36 · 707 filings